Selected research
Industry Research
In Vitro Pharmacodynamic Evaluation Industry Research Report 2026
Market perspective
The global In Vitro Pharmacodynamic Evaluation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for In Vitro Pharmacodynamic Evaluation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for In Vitro Pharmacodynamic Evaluation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for In Vitro Pharmacodynamic Evaluation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of In Vitro Pharmacodynamic Evaluation include Eurofins Discovery, Creative Biolabs, Charles River Laboratories, Pharmalegacy, Shanghai Model Organisms Center, Inc., Nanjing Probio Biotech Co., Ltd., Shanghai Genechem Co., Ltd., Shanghai InnoStar Bio-tech Co., Ltd. and Shanghai Taichu Biotechnology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global In Vitro Pharmacodynamic Evaluation market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In Vitro Pharmacodynamic Evaluation Market by Company
Eurofins Discovery
Creative Biolabs
Charles River Laboratories
Pharmalegacy
Shanghai Model Organisms Center, Inc.
Nanjing Probio Biotech Co., Ltd.
Shanghai Genechem Co., Ltd.
Shanghai InnoStar Bio-tech Co., Ltd.
Shanghai Taichu Biotechnology Co., Ltd.
VIA Biotech (Shanghai) Co., Ltd.
Alphamab Co. Ltd
Sino Biological,Inc.
In Vitro Pharmacodynamic Evaluation Segment by Type
Cell Proliferation Evaluation
Antibacterial Evaluation
Antiviral Evaluation
Others
In Vitro Pharmacodynamic Evaluation Segment by Application
Hospital
Research Institution
In Vitro Pharmacodynamic Evaluation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Pharmacodynamic Evaluation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Pharmacodynamic Evaluation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Pharmacodynamic Evaluation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of In Vitro Pharmacodynamic Evaluation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of In Vitro Pharmacodynamic Evaluation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of In Vitro Pharmacodynamic Evaluation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cell Proliferation Evaluation
- Antibacterial Evaluation
- Antiviral Evaluation
- Others
Applications
- Hospital
- Research Institution
Companies covered
- Eurofins Discovery
- Creative Biolabs
- Charles River Laboratories
- Pharmalegacy
- Shanghai Model Organisms Center, Inc.
- Nanjing Probio Biotech Co., Ltd.
- Shanghai Genechem Co., Ltd.
- Shanghai InnoStar Bio-tech Co., Ltd.
- Shanghai Taichu Biotechnology Co., Ltd.
- VIA Biotech (Shanghai) Co., Ltd.
- Alphamab Co. Ltd
- Sino Biological,Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global In Vitro Pharmacodynamic Evaluation Market Size (2021-2032)
- 2.2.2 Global In Vitro Pharmacodynamic Evaluation Sales (2021-2032)
- 2.2.3 Global In Vitro Pharmacodynamic Evaluation Market Average Price (2021-2032)
- 2.3 In Vitro Pharmacodynamic Evaluation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cell Proliferation Evaluation
- 2.3.3 Antibacterial Evaluation
- 2.3.4 Antiviral Evaluation
- 2.3.5 Others
- 2.4 In Vitro Pharmacodynamic Evaluation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Research Institution
3 Market Competitive Landscape by Manufacturers
- 3.1 Global In Vitro Pharmacodynamic Evaluation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global In Vitro Pharmacodynamic Evaluation Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global In Vitro Pharmacodynamic Evaluation Revenue of Manufacturers (2021-2026)
- 3.4 Global In Vitro Pharmacodynamic Evaluation Average Price by Manufacturers (2021-2026)
- 3.5 Global In Vitro Pharmacodynamic Evaluation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of In Vitro Pharmacodynamic Evaluation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of In Vitro Pharmacodynamic Evaluation, Product Type & Application
- 3.8 Global Manufacturers of In Vitro Pharmacodynamic Evaluation, Established Date
- 3.9 Global In Vitro Pharmacodynamic Evaluation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eurofins Discovery
- 4.1.1 Eurofins Discovery Company Information
- 4.1.2 Eurofins Discovery Business Overview
- 4.1.3 Eurofins Discovery In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eurofins Discovery In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.1.5 Eurofins Discovery Recent Developments
- 4.2 Creative Biolabs
- 4.2.1 Creative Biolabs Company Information
- 4.2.2 Creative Biolabs Business Overview
- 4.2.3 Creative Biolabs In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Creative Biolabs In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.2.5 Creative Biolabs Recent Developments
- 4.3 Charles River Laboratories
- 4.3.1 Charles River Laboratories Company Information
- 4.3.2 Charles River Laboratories Business Overview
- 4.3.3 Charles River Laboratories In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Charles River Laboratories In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.3.5 Charles River Laboratories Recent Developments
- 4.4 Pharmalegacy
- 4.4.1 Pharmalegacy Company Information
- 4.4.2 Pharmalegacy Business Overview
- 4.4.3 Pharmalegacy In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pharmalegacy In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.4.5 Pharmalegacy Recent Developments
- 4.5 Shanghai Model Organisms Center, Inc.
- 4.5.1 Shanghai Model Organisms Center, Inc. Company Information
- 4.5.2 Shanghai Model Organisms Center, Inc. Business Overview
- 4.5.3 Shanghai Model Organisms Center, Inc. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Model Organisms Center, Inc. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.5.5 Shanghai Model Organisms Center, Inc. Recent Developments
- 4.6 Nanjing Probio Biotech Co., Ltd.
- 4.6.1 Nanjing Probio Biotech Co., Ltd. Company Information
- 4.6.2 Nanjing Probio Biotech Co., Ltd. Business Overview
- 4.6.3 Nanjing Probio Biotech Co., Ltd. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nanjing Probio Biotech Co., Ltd. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.6.5 Nanjing Probio Biotech Co., Ltd. Recent Developments
- 4.7 Shanghai Genechem Co., Ltd.
- 4.7.1 Shanghai Genechem Co., Ltd. Company Information
- 4.7.2 Shanghai Genechem Co., Ltd. Business Overview
- 4.7.3 Shanghai Genechem Co., Ltd. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanghai Genechem Co., Ltd. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.7.5 Shanghai Genechem Co., Ltd. Recent Developments
- 4.8 Shanghai InnoStar Bio-tech Co., Ltd.
- 4.8.1 Shanghai InnoStar Bio-tech Co., Ltd. Company Information
- 4.8.2 Shanghai InnoStar Bio-tech Co., Ltd. Business Overview
- 4.8.3 Shanghai InnoStar Bio-tech Co., Ltd. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai InnoStar Bio-tech Co., Ltd. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.8.5 Shanghai InnoStar Bio-tech Co., Ltd. Recent Developments
- 4.9 Shanghai Taichu Biotechnology Co., Ltd.
- 4.9.1 Shanghai Taichu Biotechnology Co., Ltd. Company Information
- 4.9.2 Shanghai Taichu Biotechnology Co., Ltd. Business Overview
- 4.9.3 Shanghai Taichu Biotechnology Co., Ltd. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai Taichu Biotechnology Co., Ltd. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.9.5 Shanghai Taichu Biotechnology Co., Ltd. Recent Developments
- 4.10 VIA Biotech (Shanghai) Co., Ltd.
- 4.10.1 VIA Biotech (Shanghai) Co., Ltd. Company Information
- 4.10.2 VIA Biotech (Shanghai) Co., Ltd. Business Overview
- 4.10.3 VIA Biotech (Shanghai) Co., Ltd. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 VIA Biotech (Shanghai) Co., Ltd. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.10.5 VIA Biotech (Shanghai) Co., Ltd. Recent Developments
- 4.11 Alphamab Co. Ltd
- 4.11.1 Alphamab Co. Ltd Company Information
- 4.11.2 Alphamab Co. Ltd Business Overview
- 4.11.3 Alphamab Co. Ltd In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Alphamab Co. Ltd In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.11.5 Alphamab Co. Ltd Recent Developments
- 4.12 Sino Biological,Inc.
- 4.12.1 Sino Biological,Inc. Company Information
- 4.12.2 Sino Biological,Inc. Business Overview
- 4.12.3 Sino Biological,Inc. In Vitro Pharmacodynamic Evaluation Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Sino Biological,Inc. In Vitro Pharmacodynamic Evaluation Product Portfolio
- 4.12.5 Sino Biological,Inc. Recent Developments
5 Global In Vitro Pharmacodynamic Evaluation Market Scenario by Region
- 5.1 Global In Vitro Pharmacodynamic Evaluation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global In Vitro Pharmacodynamic Evaluation Sales by Region: 2021-2032
- 5.2.1 Global In Vitro Pharmacodynamic Evaluation Sales by Region: 2021-2026
- 5.2.2 Global In Vitro Pharmacodynamic Evaluation Sales by Region: 2027-2032
- 5.3 Global In Vitro Pharmacodynamic Evaluation Revenue by Region: 2021-2032
- 5.3.1 Global In Vitro Pharmacodynamic Evaluation Revenue by Region: 2021-2026
- 5.3.2 Global In Vitro Pharmacodynamic Evaluation Revenue by Region: 2027-2032
- 5.4 North America In Vitro Pharmacodynamic Evaluation Market Facts & Figures by Country
- 5.4.1 North America In Vitro Pharmacodynamic Evaluation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America In Vitro Pharmacodynamic Evaluation Sales by Country (2021-2032)
- 5.4.3 North America In Vitro Pharmacodynamic Evaluation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe In Vitro Pharmacodynamic Evaluation Market Facts & Figures by Country
- 5.5.1 Europe In Vitro Pharmacodynamic Evaluation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe In Vitro Pharmacodynamic Evaluation Sales by Country (2021-2032)
- 5.5.3 Europe In Vitro Pharmacodynamic Evaluation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific In Vitro Pharmacodynamic Evaluation Market Facts & Figures by Country
- 5.6.1 Asia Pacific In Vitro Pharmacodynamic Evaluation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific In Vitro Pharmacodynamic Evaluation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific In Vitro Pharmacodynamic Evaluation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America In Vitro Pharmacodynamic Evaluation Market Facts & Figures by Country
- 5.7.1 South America In Vitro Pharmacodynamic Evaluation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America In Vitro Pharmacodynamic Evaluation Sales by Country (2021-2032)
- 5.7.3 South America In Vitro Pharmacodynamic Evaluation Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa In Vitro Pharmacodynamic Evaluation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa In Vitro Pharmacodynamic Evaluation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa In Vitro Pharmacodynamic Evaluation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa In Vitro Pharmacodynamic Evaluation Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global In Vitro Pharmacodynamic Evaluation Sales by Type (2021-2032)
- 6.1.1 Global In Vitro Pharmacodynamic Evaluation Sales by Type (2021-2032) & (k units)
- 6.1.2 Global In Vitro Pharmacodynamic Evaluation Sales Market Share by Type (2021-2032)
- 6.2 Global In Vitro Pharmacodynamic Evaluation Revenue by Type (2021-2032)
- 6.2.1 Global In Vitro Pharmacodynamic Evaluation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global In Vitro Pharmacodynamic Evaluation Revenue Market Share by Type (2021-2032)
- 6.3 Global In Vitro Pharmacodynamic Evaluation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global In Vitro Pharmacodynamic Evaluation Sales by Application (2021-2032)
- 7.1.1 Global In Vitro Pharmacodynamic Evaluation Sales by Application (2021-2032) & (k units)
- 7.1.2 Global In Vitro Pharmacodynamic Evaluation Sales Market Share by Application (2021-2032)
- 7.2 Global In Vitro Pharmacodynamic Evaluation Revenue by Application (2021-2032)
- 7.2.1 Global In Vitro Pharmacodynamic Evaluation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global In Vitro Pharmacodynamic Evaluation Revenue Market Share by Application (2021-2032)
- 7.3 Global In Vitro Pharmacodynamic Evaluation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 In Vitro Pharmacodynamic Evaluation Value Chain Analysis
- 8.1.1 In Vitro Pharmacodynamic Evaluation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 In Vitro Pharmacodynamic Evaluation Production Mode & Process
- 8.2 In Vitro Pharmacodynamic Evaluation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 In Vitro Pharmacodynamic Evaluation Distributors
- 8.2.3 In Vitro Pharmacodynamic Evaluation Customers
9 Global In Vitro Pharmacodynamic Evaluation Analyzing Market Dynamics
- 9.1 In Vitro Pharmacodynamic Evaluation Industry Trends
- 9.2 In Vitro Pharmacodynamic Evaluation Industry Drivers
- 9.3 In Vitro Pharmacodynamic Evaluation Industry Opportunities and Challenges
- 9.4 In Vitro Pharmacodynamic Evaluation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst